These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11907668)

  • 1. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure.
    Chatellier D; Jourdain M; Mangalaboyi J; Ader F; Chopin C; Derambure P; Fourrier F
    Intensive Care Med; 2002 Feb; 28(2):214-7. PubMed ID: 11907668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery.
    Manns B; Doig CJ; Lee H; Dean S; Tonelli M; Johnson D; Donaldson C
    Crit Care Med; 2003 Feb; 31(2):449-55. PubMed ID: 12576950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime.
    Smith NL; Freebairn RC; Park MA; Wallis SC; Roberts JA; Lipman J
    Crit Care Resusc; 2012 Dec; 14(4):312-5. PubMed ID: 23230881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity induced by Cefepime in a very old hemodialysis patient.
    Ferrara N; Abete P; Giordano M; Ferrara P; Carnovale V; Leosco D; Beneduce F; Ciarambino T; Varricchio M; Rengo F
    Clin Nephrol; 2003 May; 59(5):388-90. PubMed ID: 12779103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood purification therapy in treatment of acute renal failure in infants with melamine-induced stones.
    Shen Y; Liu XR; Zhang GJ; Zhou N
    Chin Med J (Engl); 2009 Feb; 122(3):257-61. PubMed ID: 19236800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal failure is a risk factor for cefepime-induced encephalopathy.
    Garces EO; Andrade de Anzambuja MF; da Silva D; Bragatti JA; Jacoby T; Saldanha Thomé F
    J Nephrol; 2008; 21(4):526-34. PubMed ID: 18651542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Lam S; Gomolin IH
    Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
    Brause M; Neumann A; Schumacher T; Grabensee B; Heering P
    Crit Care Med; 2003 Mar; 31(3):841-6. PubMed ID: 12626994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis.
    Maynor LM; Carl DE; Matzke GR; Gehr TW; Farthing C; Farthing D; Brophy DF
    Pharmacotherapy; 2008 Aug; 28(8):977-83. PubMed ID: 18657014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit.
    Chang JW; Yang WS; Seo JW; Lee JS; Lee SK; Park SK
    Scand J Urol Nephrol; 2004; 38(5):417-21. PubMed ID: 15764254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.
    Haase M; Bellomo R; Baldwin I; Haase-Fielitz A; Fealy N; Davenport P; Morgera S; Goehl H; Storr M; Boyce N; Neumayer HH
    Am J Kidney Dis; 2007 Aug; 50(2):296-304. PubMed ID: 17660031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.
    Stegmayr BG; Banga R; Berggren L; Norda R; Rydvall A; Vikerfors T
    Crit Care Med; 2003 Jun; 31(6):1730-6. PubMed ID: 12794412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.
    Grill MF; Maganti R
    Ann Pharmacother; 2008 Dec; 42(12):1843-50. PubMed ID: 19033476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
    Lins RL; Elseviers MM; Van der Niepen P; Hoste E; Malbrain ML; Damas P; Devriendt J;
    Nephrol Dial Transplant; 2009 Feb; 24(2):512-8. PubMed ID: 18854418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier penetration of cefepime after neurosurgery.
    Wang JF; Wang Q; Zhao LH; Shi GZ; Zhou JX
    Chin Med J (Engl); 2007 Jul; 120(13):1176-8. PubMed ID: 17637248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.